CLINICAL ROLE -
A Training Program Addresses Challenges in USP <797> Personnel Competency Evaluations at a Multisite Institution
Implementing these standards can be logistically challenging.
Pharmacy-Led Medication Reconciliation Is Best Practice
The TJC and IHI advocate for medication reconciliation at all transitions of care.
Ryan’s Law Is a Monumental Opportunity for Pharmacists
Pharmacists can help to usher in a new era of patient-centered end-of-life care.
Common Patient Questions About Insulin Biosimilars Pertain to Classification
Nuances can lead to frequent areas of confusion.
The Promise of Biosimilars Is Within Reach for Health Systems
A collaborative exercise with 16 health care organizations nets millions in savings.
Artificial Intelligence Is Revolutionizing Controlled Substance Diversion Detection
AI is able to quickly analyze, identify, and route data for investigation.
Despite a Lack of US Guidelines, Implementing β-Lactam Therapeutic Drug Monitoring Remains Key
This step-by-step primer describes the implementation process for β-lactam TDM.
Defining Value in a Biosimilar Strategy Depends on Perspective
Enhanced utilization of biosimilar products can have significant impact on reducing the overall cost of health care and potentially reducing out-of-pocket costs for patients.
Complexities Arise as We Progress Toward the DSCSA Final Implementation Landmark
As we approach November 27, 2024, new regulations and updates may arise for health system pharmacies to be aware of to remain compliant.
